You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 July 2026 - Biotechnology company Decoy Therapeutics Inc (Nasdaq: DCOY) reported on Monday that a D-MAV antiviral candidate demonstrated in vitro activity against wild-type Ebola Zaire virus, expanding the company's Designable Multi-Antiviral...
27 July 2026 - Biopharmaceutical company Harbour BioMed (HKEX: 02142) declared on Monday that it has entered into a strategic collaboration with China National Pharmaceutical Group Co Ltd (Sinopharm) to establish the Sinopharm - Harbour BioMed Innova...
27 July 2026 - Immunology innovation company argenx (Euronext & Nasdaq: ARGX) disclosed on Monday that it has entered into a definitive agreement to acquire biopharmaceutical company Forte Biosciences Inc (Nasdaq: FBRX) for USD77 per share in cas...
27 July 2026 - Infection prevention company Tristel plc (AIM: TSTL) announced on Monday that it has commercially launched 3T Pro, a premium tier of its 3T digital compliance platform, marking the first paid version of the platform as the company seek...
27 July 2026 - Late-stage biopharmaceutical company NewAmsterdam Pharma Company N.V. (Nasdaq:NAMS) and its partner Menarini Group announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA...
27 July 2026 - Injectables manufacturer American Regent Inc announced on Friday that it is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level.The prod...
24 July 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Trodelvy (sacit...